Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo

Abstract Background Schistosomiasis is a debilitating and neglected tropical disease for which praziquantel (PZQ) remains the first-choice drug for treatment and control of the disease. In our previous studies, we found that the patented compound DW-3-15 (patent no. ZL201110142538.2) displayed signi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zi-Yin Yang, Zi-Hao Liu, Ya-Nan Zhang, Chen Li, Lei Liu, Wen-Jie Pu, Shi-Qi Xie, Jing Xu, Chao-Ming Xia
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-10-01
coleção:	Parasites & Vectors
Assuntos:	Schistosoma japonicum Praziquantel DW-3-15 Synergistic effect Combination chemotherapy
Acesso em linha:	https://doi.org/10.1186/s13071-021-05065-x
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!